Women who experience a false positive mammogram were more likely to delay their subsequent screening, potentially increasing the risk of having late stage breast cancer at diagnosis.
Survey data from patients receiving care at Boston Medical Center who were navigated for colonoscopy screening illustrates how patients value the services of oncology patient navigators.
Researchers report on their evaluation of the impact of the 2012 USPSTF recommendation on volumes of prostate biopsy and radical prostatectomy.
Lesion-directed screening (LDS) for skin cancer has similar detection rate as total-body examination, but takes much less time.
Despite advances in treatment, finding smaller tumors has been linked to better survival results.
Although the software can be helpful, it does not appear to improve cancer detection rates.
The number of high-risk women deemed eligible for primary prevention may be increased by incorporating benign breast disease (BBD) diagnoses into the Breast Cancer Surveillance Consortium (BCSC) risk model, according to a study.
Elevated levels of three proteins were detected in the urine of patients with early-stage pancreatic cancer.
Results of blood tests to detect DNA shed from tumors were found to predict cancer recurrence far earlier than standard imaging methods.
Revised guidelines for thyroid cancer testing now both incorporate personalized medicine and the latest tests.
Study shows potential for noninvasive tumor detection for head and neck cancer.
Incorporating maternal plasma cell-free DNA into routine noninvasive prenatal testing (NIPT) could aid early detection of maternal tumors, according to study data.
Most frequently biopsied incidental malignancies were seen on the head and neck.
New research indicates that magnetic resonance imaging (MRI) might have a role in early detection for those at high genetic risk of pancreatic cancer.
Certain conditions make it harder to reliably detect tumors, and regions with locally-endemic infectious lung diseases pose an added hurdle for lung cancer detection.
A new screening technique, MR fusion guided prostate biopsy, holds promise for increased prostate cancer detection.
By 2024, the number of Americans with a history of cancer is expected to grow to 19 million.
Researchers have developed a breathalyzer that can detect lung cancer and assess whether it is early or advanced, according to findings presented at the 2014 annual meeting of the American Society of Clinical Oncology.
Panel distinguishes early cancer from healthy controls, chronic pancreatitis, benign cysts
Panels of microRNA expression can potentially distinguish pancreatic cancer from healthy controls, according to a study.
New findings that run counter to federal recommendations indicate that women should be encouraged to initiate regular mammographic screening before age 50 years.
Free screenings for head and neck cancer can increase early detection and provide an opportunity to educate people about risk factors. But who is most likely to attend these screenings, and what do attendees know about head and neck cancer?
Most deaths from breast cancer occur in younger women who do not receive regular mammograms, according to a new study. The study indicates that regular screening before age 50 years should be encouraged.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal, according to a new study.
Carbohydrate antigen 125 (CA125) testing, already used to predict ovarian cancer recurrence, has now shown strong results as a screening technique for early-stage disease when combined with transvaginal ultrasound.
Algorithm is used to estimate risk of ovarian cancer in postmenopausal women and demonstrates high specificity.
A considerable proportion of children with melanoma do not present with conventional ABCDE detection criteria.
A telephone outreach intervention delivered by Medicaid managed care organization (MMCO) staff can increase rates of colorectal cancer (CRC) screening among women overdue for screening, according to a study.
Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
- Immunotherapy and the Future of Prostate Cancer Treatment
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|